Emergence of carbapenem-resistant klebsiella pneumoniae: Progressive spread and four-year period of observation in a cardiac surgery division

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Lombardi, Fortunata ^a   Gaia, Paola ^a   Valaperta, Rea ^a   Cornetta, Maria ^a   Tejada, Milvana Rosa ^a   Di Girolamo, Luca ^a   Moroni, Alessandra ^a   Ramundo, Federica ^a   Colombo, Alessio ^b   Valisi, Massimiliano ^b   Costa, Elena ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b Fleming Research   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE; TIGECYCLINE; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; VIM-1 METALLO-BETA-LACTAMASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CHILD; CLONAL VARIATION; FEMALE; GENETIC VARIABILITY; HEART SURGERY; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS; DRUG EFFECTS; GENETICS; HIGH THROUGHPUT SEQUENCING; KLEBSIELLA INFECTIONS; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PRESCHOOL CHILD; VERY ELDERLY;

KLEBSIELLA PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; COLISTIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED;

EID: 84929649098     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/871947     Document Type: Article

References (32)

1. E. Bouza, J. Hortal, P. Mun~oz et al., "Infections following major heart surgery in European intensive care units: there is roomfor improvement (ESGNI 007 Study), " Journal of Hospital Infection, vol. 63, no. 4, pp. 399-405, 2006.
2. V. G. Fowler Jr., S. M. O'Brien, L. H. Muhlbaier, G. R. Corey, T. B. Ferguson, and E. D. Peterson, "Clinical predictors of major infections after cardiac surgery, " Circulation, vol. 112, no. 9, pp. 358-365, 2005.
3. R. Podschun and U. Ullmann, "Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors, " ClinicalMicrobiology Reviews, vol. 11, no. 4, pp. 589-603, 1998.
4. G. Patel and R. A. Bonomo, "Status report on carbapenemases: challenges and prospects, " Expert Review of Anti-Infective Therapy, vol. 9, no. 5, pp. 555-570, 2011.
5. S. Bratu, S. Brooks, S. Burney et al., "Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York, " Clinical Infectious Diseases, vol. 44, no. 7, pp. 972-975, 2007.
6. E. Mouloudi, E. Protonotariou, A. Zagorianou et al., "Bloodstream infections caused by metallo-? -lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes, " Infection Control and Hospital Epidemiology, vol. 31, no. 12, pp. 1250-1256, 2010.
7. D. M. Sievert, P. Ricks, J. R. Edwards et al., "Antimicrobialresistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010, " Infection Control andHospital Epidemiology, vol. 34, no. 1, pp. 1-14, 2013.
8. D. P. Kofteridis, A. Valachis, D. Dimopoulou et al., "Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a cas-case-control study, " Journal of Infection and Chemotherapy, vol. 20, no. 5, pp. 293-297, 2014.
9. I. Lola, S. Levidiotou, A. Petrou, H. Arnaoutoglou, E. Apostolakis, and G. S. Papadopoulos, "Are there independent predisposing factors for postoperative infections following open heart surgery?" Journal of Cardiothoracic Surgery, vol. 6, article 151, 2011.
10. K. S. Kaye, A. D. Harris, M. Samore, and Y. Carmeli, "The casecase-control study design: addressing the limitations of risk factor studies for antimicrobial resistance, " InfectionControl and Hospital Epidemiology, vol. 26, no. 4, pp. 346-351, 2005.
11. P. A. Bradford, S. Bratu, C. Urban et al., "Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30? -Lactamases in New York City, " Clinical Infectious Diseases, vol. 39, no. 1, pp. 55-60, 2004.
12. S. Bratu, D. Landman, R. Haag et al., "Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium, " Archives of Internal Medicine, vol. 165, no. 12, pp. 1430-1435, 2005.
13. S. Bratu, M. Mooty, S. Nichani et al., "Emergence of KPCpossessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection, " Antimicrobial Agents and Chemotherapy, vol. 49, no. 7, pp. 3018-3020, 2005.
14. P. Giakkoupi, A. Xanthaki, M. Kanelopoulo et al., "VIM-1 metallo-? -Lactamase-producing Klebsiella pneumoniae strains in Greek hospitals, " Journal of Clinical Microbiology, vol. 41, no. 8, pp. 3893-3896, 2003.
15. A. Ikonomidis, D. Tokatlidou, I. Kristo et al., "Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a blaVIM-1 metallo-?- Lactamase gene, " Journal of Clinical Microbiology, vol. 43, no. 10, pp. 5344-5347, 2005.
16. N. Woodford, P. M. Tierno Jr., K. Young et al., "Outbreak of Klebsiella pneumoniae producing a new carbapenemhydrolyzing class A? -Lactamase, KPC-3, in aNewYorkMedical Center, " Antimicrobial Agents and Chemotherapy, vol. 48, no. 12, pp. 4793-4799, 2004.
17. H. Yigit, A. M. Queenan, G. J. Anderson et al., "Novel carbapenem-hydrolyzing? -Lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae, " Antimicrobial Agents and Chemotherapy, vol. 45, no. 4, pp. 1151-1161, 2001.
18. S. Nobari, F. Shahcheraghi, F. R. Ghezelgeh, and B. Valizadeh, "Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated fromIranian patients: first identification of blaKPC gene in Iran, " Microbial Drug Resistance, vol. 20, no. 4, pp. 285-293, 2014.
19. L. Diancourt, V. Passet, J. Verhoef, P. A. D. Grimont, and S. Brisse, "Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates, " Journal of Clinical Microbiology, vol. 43, no. 8, pp. 4178-4182, 2005.
20. F. C. Tenover, R. D. Arbeit, R. V. Goering et al., "Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing, " Journal of Clinical Microbiology, vol. 33, no. 9, pp. 2233-2239, 1995.
21. O. Zarkotou, S. Pournaras, P. Tselioti et al., "Predictors of mortality in patients with bloodstream infections caused by KPCproducing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment, " Clinical Microbiology and Infection, vol. 17, no. 12, pp. 1798-1803, 2011.
22. R. Cantón, M. Akóva, Y. Carmeli et al., "Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe, " Clinical Microbiology and Infection, vol. 18, no. 5, pp. 413-431, 2012.
23. P. Ciobotaro, M. Oved, E. Nadir, R. Bardenstein, and O. Zimhony, "An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice, " The American Journal of Infection Control, vol. 39, no. 8, pp. 671-677, 2011.
24. P. Di Carlo, G. Gulotta, A. Casuccio et al., "KPC-3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients, " BMC Anesthesiology, vol. 13, article 13, 2013.
25. T. Kelesidis, D. E. Karageorgopoulos, I. Kelesidis, and M. E. Falagas, "Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies, " Journal of Antimicrobial Chemotherapy, vol. 62, no. 5, pp. 895-904, 2008.
26. I. Karaiskos and H. Giamarellou, "Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches, " Expert Opinion on Pharmacotherapy, vol. 15, no. 10, pp. 1351-1370, 2014.
27. Z. A. Qureshi, D. L. Paterson, B. A. Potoski et al., "Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens, " AntimicrobialAgents and Chemotherapy, vol. 56, no. 4, pp. 2108-2113, 2012.
28. G. C. Lee and D. S. Burgess, "Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae, " Journal of Clinical Medicine Research, vol. 5, no. 2, pp. 97-100, 2013.
29. M. E. Falagas, P. Lourida, P. Poulikakos, P. I. Rafailidis, and G. S. Tansarli, "Antibiotic treatment of infections due to carbapenemresistant enterobacteriaceae: systematic evaluation of the available evidence, " Antimicrobial Agents and Chemotherapy, vol. 58, no. 2, pp. 654-663, 2014.
30. C. Tascini, E. Tagliaferri, T. Giani et al., "Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing Klebsiella pneumoniae, " Antimicrobial Agents and Chemotherapy, vol. 57, no. 8, pp. 3990-3993, 2013.
31. T. Tängdén, R. A. Hickman, P. Forsberg, P. Lagerbäck, C. G. Giske, and O. Cars, "Evaluation of double-and triple-antibiotic combinations for VIM-and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments, " Antimicrobial Agents and Chemotherapy, vol. 58, no. 3, pp. 1757-1762, 2014.
32. A. P. Zavascki, J. B. Bulitta, andC. B. Landersdorfer, "Combination therapy for carbapenem-resistant Gram-negative bacteria, " Expert Review of Anti-Infective Therapy, vol. 11, no. 12, pp. 1333-1353, 2013.